Item Text

10. PROOF OF CLAIM FOR INCLUSION IN SETTLEMENT REGARDING IN RE FLONASE ANTITRUST LITIGATION CIVIL ACTION NO. 08–CV–3301 Approve the Proof of Claim submitted by Maricopa County for inclusion in the settlement of a certified class action filed by other entities for reimbursement of overpayments made for certain brand-name prescription drugs. Authorize compromise of the claim in the amount of $3,437.36. This request concerns the lawsuit entitled In re FLONASE ANTITRUST LITIGATION. Civil Action No. 08–CV–3301. Multiple employee welfare benefit plans brought this antitrust action alleging, among other things, that prescription drug manufacturer GlaxoSmithKline (GSK) filed sham citizens petitions with Food and Drug Administration (FDA) in order to delay entry of generic version of Flonase into market, and asserting claims for monopolization, unfair and deceptive practices, and unjust enrichment. The suit further alleges that as a result of GSK’s actions, consumers were injured by paying more for Flonase nasal spray than they would have paid otherwise had less expensive, generic versions of Flonase been available. GlaxoSmithKline has agreed to pay $35 million to settle the claims asserted. Maricopa County filed a Proof of Claim on August 15, 2013. The class settlement provides for payment of Maricopa County’s claim in the amount of $3,437.36. The Board is requested to approve the Proof of Claim submitted and authorize the compromise of the claim in the amount of $3,437.36. (C-39-15-013-S-00)